Search for another bill
Search for another bill or initiative
SB 6183 - 2025-26
Concerning coverage for HIV antiviral drugs.
Bill status-at-a-glance
As of Saturday, March 7, 2026 01:34 AM
Current status:
HSpkr Signed
Where is it in the process?
Bill status-at-a-glance
As of Saturday, March 7, 2026 01:34 AM
Current status:
HSpkr Signed
Where is it in the process?
Bill history
2026 Regular Session
In the Senate
Jan 16
First reading, referred to Health & Long-Term Care.
(View original bill)
Jan 22
Public hearing in the Senate Committee on Health & Long-Term Care at 8:00 AM.
(Committee materials)
Jan 27
Executive action taken in the Senate Committee on Health & Long-Term Care at 10:30 AM.
(Committee materials)
HLTC - Majority; 1st substitute bill be substituted, do pass.
(View 1st substitute)
(Majority report)
Minority; without recommendation.
(Minority report)
Jan 29
Passed to Rules Committee for second reading.
Feb 4
Placed on second reading by Rules Committee.
Feb 10
1st substitute bill substituted (HLTC 26).
(View 1st substitute)
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 48; nays, 0; absent, 0; excused, 1.
(View this roll call)
In the House
Feb 12
First reading, referred to Health Care & Wellness.
Feb 24
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee materials)
Feb 25
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee materials)
HCW - Majority; do pass.
(Majority report)
Referred to Rules 2 Review.
Mar 2
Rules Committee relieved of further consideration. Placed on second reading.
Mar 3
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 93; nays, 1; absent, 0; excused, 4.
(View this roll call)
In the Senate
Mar 4
President signed.
In the House
Mar 5
Speaker signed.
Available documents
For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.
Fiscal note
Amendments
Available videos